These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3987835)

  • 1. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
    Marsh JC
    Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
    Marsh JC; Brown BJ; Nierenburg MM
    Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate.
    Marsh JC
    Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivities of human and murine hemopoietic cells exposed to cytotoxic drugs in an in vivo culture system.
    Gordon MY; Blackett N
    Cancer Res; 1976 Aug; 36(8):2822-6. PubMed ID: 1277192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
    Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
    Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of methotrexate, two nonclassic folic acid antagonists, and cytarabine on hematopoietic precursor cells.
    Marsh JC
    Cancer Treat Rep; 1982 Mar; 66(3):499-504. PubMed ID: 6460555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2'3'-Dideoxycytidine-induced thymic lymphoma correlates with species-specific suppression of a subpopulation of primitive hematopoietic progenitor cells in mouse but not rat or human bone marrow.
    Irons RD; Le AT; Som DB; Stillman WS
    J Clin Invest; 1995 Jun; 95(6):2777-82. PubMed ID: 7539460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE; Socquet M; Delforge A; Stryckmans P
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemopoietic progenitor cells in the blood as indicators of the functional status of the bone marrow after total-body and partial-body irradiation: experiences from studies in dogs.
    Nothdurft W; Kreja L
    Stem Cells; 1998; 16 Suppl 1():97-111. PubMed ID: 11012152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans.
    van Tellingen O; Nooijen WJ; Schaaf LJ; van der Valk M; van Asperen J; Henrar RE; Beijnen JH
    Cancer Res; 1998 Jun; 58(11):2410-6. PubMed ID: 9622082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
    Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
    Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hydroxyurea on the number of hematopoietic stem cells, stromal cell precursors and cell precursors of thymus lymphoid tissue in the bone marrow of mice during aging].
    Sidorenko AV; Andrianova LF
    Tsitologiia; 1984 Jul; 26(7):813-7. PubMed ID: 6485091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
    Fairbairn LJ; Chinnasamy N; Lashford LS; Chinnasamy D; Rafferty JA
    Cancer Gene Ther; 2000 Feb; 7(2):233-9. PubMed ID: 10770631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
    Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for measuring suppression of hematopoiesis.
    Chervenick PA
    Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A.H.E.A.D. method: a quantitative automated measurement of the hematotoxicity of anticancer drugs.
    Saint-Dizier D; Sancier M; Cudennec CA
    Anticancer Res; 1990; 10(3):765-71. PubMed ID: 2369090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.